The precipitous decline in shares of so-called Yield Companies confirms our suspicions of their dubious quality. Read More

Drug company is the poster child for overvalued momentum stocks. Read More

Drug company is the poster child for overvalued momentum stocks. Read More

European companies are still showing a clear preference for boosting payouts. Read More

The sector flunked the test of plunging oil prices but did yield a few oddball winners.  Read More

The oil patch holds another bounty: tax losses. Here’s a smart way to harvest them.  Read More

Nuveen’s top asset manager, Robert C. Doll, predicts more volatility and lower returns as he says the “easy money” has been made. Read More

It is unlikely that the election of the Liberal Party as the new Canadian Government will have any major impact on the financial markets in the immediate future. The prospects for a considerable portion of the major listed companies are mainly influenced by global growth and commodity prices, rather than… Read More

A new round of consolidation could be about to work its way through the semiconductor industry. There were various reports circulating last week about some potential large deals percolating across the space. In an overall industry that is only getting more competitive, chipmakers know that if they get bigger via… Read More

I remain positive on Next Wave Portfolio holding Qualys (QLYS) for the long term based on a number of factors, and believe the recent sharp pullback in the stock provided a more attractive entry level from a risk/reward perspective. Shares of the provider of cloud-based enterprise security solutions fell to… Read More